Blog
Osmind News

Osmind News

Get the latest updates from Osmind and stay informed about key developments in the mental health technology landscape.

Osmind and UBC partner to Advance Mental Health Treatment Through REMS Innovation

Osmind Increases Access to Breakthrough Mental Health Treatments through Partnerships with Enthea and First Tracks Health

Osmind Welcomes Dr. Robert M. Berman, M.D. as Strategic Advisor

Osmind Welcomes Dr. Husseini K. Manji, M.D., F.R.C.P.C., as a Strategic Advisor

Osmind Announces Collaboration with the American Psychiatric Association

2024 Community Advisory Board: Clinicians and Thought Leaders Shaping The Future of Mental Health

Osmind 2023 Year in Review: A Breakthrough Year for Mental Health Care

Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

Osmind Reviews Are In for the Best Mental Health EHR

Osmind Recognized as Quarterfinalist in the 2023 Digital Health Awards

Shaping the Future of Psychedelic Treatments: Osmind's Response to FDA's Draft Guidance

Osmind Announces Publication of Largest Real-World Study on Effectiveness of Ketamine Intravenous Therapy for Depression, Anxiety and Suicidal Ideation

Tune Into Psychiatry's Next Frontier: Introducing the Psychiatry Tomorrow Podcast

Osmind in the News: Innovations in Mental Healthcare and the Promise of Public Benefit Corporations

Safeguarding Mental Health Telepractice: A Call to Action on the DEA's Proposed Rule Changes

Bridging the Gap Between Research and Practice: Insights from Osmind's Research Interest Survey

Announcing the Community Advisory Board (CAB): Movers and Shakers of Psychiatry

Osmind 2022 Year in Review: A Breakthrough Year for Mental Health Care

Osmind launches integrated virtual visits, expanding care options for in-demand mental health clinicians

Osmind publishes its first public benefit corporation report

We’re proud to announce our $40M Series B Round Led by DFJ Growth

The New Osmind Logo and Brand

Osmind is selected as a partner for the American Association for Precision Medicine

Exciting news from Osmind: MoodMonitor is merging with us

Building an ethical startup in psychedelic medicine: an open dialogue

logo

Insights

AboutCareersBlogPodcastAffiliate

If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.

Osmind Inc. © 2024 All Rights Reserved.

Privacy Policy

Terms of Service